Perbedaan Organon Pharma Indonesia Tbk. dan Sunindo Pratama Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Sunindo Pratama Tbk. diperdagangkan di Rp680 (kapitalisasi pasar 1,74 T, volume 24 jam 312,4 rb). Perbedaan utamanya: Sunindo Pratama Tbk. jauh lebih besar — sekitar 16,7× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | SUNI | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 1,74 T |
Volume | — | 312,4 rb |
Lot | — | 3,12 rb |
Perputaran | — | 213,14 jt |
Harga Rata-rata | — | 682,26 |
Nilai Transaksi | — | 213,14 jt |
Harga Ekuilibrium Indikatif | — | 695 |
Volume Ekuilibrium Indikatif | — | 12,4 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT Sunindo Pratama Tbk (The Company) was established based on Notarial Deed of Shinta Dewi Sudarsana, S.H., No. 04 dated October 17, 2002.
Selengkapnya di halaman SUNI →